Abiopharma

🔍 Huang Pearl S (Director)

Company: WATERS CORP /DE/ (WAT)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 307 shares of Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,253.30 | transaction_form_type: 4 | Footnotes: F1
• Acquired 828 shares of Stock Option (Right to Buy) at $381.96 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | Exercise: 2027-01-02 | equity_swap_involved: 0 | shares_owned_after: 828.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on January 2, 2027.
• F2: All of the shares of common stock underlying this stock option will vest and become exercisable on January 2, 2027.